Compare reta vs mounjaro dosage: retatrutide is investigational and titrated up to 12 mg weekly, while Mounjaro starts at 2.5 mg and maxes at 15 mg.
Retatrutide (reta) is an investigational drug with no FDA-approved dosage, while Mounjaro (tirzepatide) is an FDA-approved medication with a standard dosing schedule. In clinical trials, retatrutide was given in weekly doses from 1 mg to 12 mg, whereas Mounjaro starts at 2.5 mg once weekly and can be increased to a maximum of 15 mg once weekly. Because retatrutide is not yet available by prescription, there is no official head-to-head dosage equivalence between these two medications.
What Is Retatrutide (Reta) and How Is It Dosed?
Retatrutide is a triple agonist that targets GIP, GLP-1, and glucagon receptors. It is currently in phase 3 clinical trials and is not approved by the FDA for any use. In phase 2 trials, participants received once-weekly subcutaneous injections of 1 mg, 4 mg, 8 mg, or 12 mg, with dose escalation every 4 weeks.
There is no standard retatrutide dosage because the drug is still experimental. Any dose used outside of a clinical trial is unregulated and potentially unsafe. The maximum dose studied in trials was 12 mg per week, but that does not mean 12 mg is safe or effective for everyone.
What Is Mounjaro (Tirzepatide) and How Is It Dosed?
Mounjaro is the brand name for tirzepatide, a dual GIP and GLP-1 receptor agonist. It is FDA-approved for type 2 diabetes, and the same active ingredient is approved under the brand name Zepbound for weight loss. People often search for tirzepatide vs mounjaro, but Mounjaro is simply tirzepatide when prescribed for diabetes.
The standard Mounjaro dosing schedule is:
- Weeks 1–4: 2.5 mg once weekly (starting dose, not for glycemic control)
- Week 5 onward: Increase to 5 mg once weekly
- Further increases: If needed, increase by 2.5 mg every 4 weeks
- Maximum dose: 15 mg once weekly
Mounjaro is titrated slowly to reduce gastrointestinal side effects. Your healthcare provider will determine the right dose for you based on your blood sugar, weight, and tolerance.
Reta vs Mounjaro Dosage: Direct Comparison
The table below summarizes the key dosage differences between retatrutide and Mounjaro.
| Feature | Retatrutide (Reta) | Mounjaro (Tirzepatide) |
|---|---|---|
| FDA status | Investigational, not approved | Approved for type 2 diabetes (Zepbound for weight loss) |
| Receptor targets | GIP, GLP-1, glucagon | GIP, GLP-1 |
| Starting dose | Not standard; trials used 1 mg weekly | 2.5 mg once weekly |
| Maximum dose | 12 mg weekly in trials | 15 mg once weekly |
| Titration schedule | Every 4 weeks in trials | Every 4 weeks (2.5 mg steps) |
| Availability | Clinical trials only | Prescription required |
A 4 mg dose of retatrutide is not equivalent to a 4 mg dose of Mounjaro. The drugs have different potencies, receptor activity, and half-lives, so you cannot convert one dose to the other. Any conversion attempt would be guesswork and is not supported by medical evidence.
How Titration Works for Both Medications
Both retatrutide and Mounjaro require gradual dose increases to minimize side effects like nausea, vomiting, and diarrhea. Mounjaro has a fixed, FDA-approved titration schedule that starts at 2.5 mg and moves up in 2.5 mg increments every 4 weeks. Retatrutide trials used a similar 4-week escalation strategy, but the starting and target doses varied by study group.
Rapid dose increases with either drug can worsen side effects. If you are prescribed Mounjaro, follow your doctor's instructions exactly. If you are considering retatrutide, remember that it is not legally available and self-dosing with research chemicals is dangerous.
Safety, Legal Status, and Medical Guidance
Retatrutide is not FDA-approved for human use in the United States. It can only be obtained through clinical trials or, illegally, from online vendors selling research peptides. Mounjaro is a prescription medication that requires a healthcare provider's oversight.
Common side effects of both drugs include nausea, diarrhea, constipation, vomiting, and abdominal pain. More serious risks include pancreatitis, gallbladder disease, and kidney problems. Always consult a licensed healthcare professional before starting or changing any weight-loss or diabetes medication.
Other Peptide Comparisons People Ask About
When considering tirzepatide vs mounjaro for weight loss, note that Mounjaro is approved only for type 2 diabetes, while Zepbound is the tirzepatide product approved for chronic weight management. Some online forums discuss tirzepatide vs semaglutide dosage reddit threads, but those comparisons involve different drug classes and FDA-approved dosing schedules.
Researchers sometimes compare reta vs mots-c, although MOTS-c is a mitochondrial-derived peptide with no approved human dosage. There is no established reta and mots-c stack dosage, and stacking investigational peptides is not recommended by any medical authority. For any weight-loss or performance goal, stick to approved treatments under medical supervision.
Key Takeaways
- Retatrutide has no FDA-approved dosage and is only available in clinical trials.
- Mounjaro (tirzepatide) is dosed from 2.5 mg to 15 mg once weekly, with increases every 4 weeks.
- Reta and Mounjaro doses are not interchangeable because the drugs have different mechanisms and potencies.
- Never use research peptides for self-treatment; consult a healthcare provider for approved options.
Frequently Asked Questions
Is retatrutide stronger than Mounjaro?
In early clinical trials, retatrutide produced greater average weight loss than tirzepatide at some doses, but the two drugs have not been directly compared in a large head-to-head trial. Retatrutide is not FDA-approved, so its long-term safety profile is unknown. Stronger does not automatically mean safer.
What is the starting dose of retatrutide?
There is no official starting dose for retatrutide because it is an investigational drug. Clinical trials have used 1 mg once weekly as a starting dose, with increases every 4 weeks up to 12 mg. You should never attempt to self-dose with retatrutide outside of a clinical trial.
Can you take retatrutide and Mounjaro together?
No, you should not take retatrutide and Mounjaro together. Retatrutide is not approved for human use, and combining two drugs that affect GLP-1 and GIP receptors can cause severe gastrointestinal and other side effects. Only a licensed healthcare provider can prescribe approved combinations of medications.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.